|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
1.9a crystal structure of hla-g
|
|
Structure:
|
 |
Mhc class i antigen. Chain: a. Fragment: hla-g heavy chain. Engineered: yes. Mutation: yes. Beta-2-microglobulin. Chain: b. Synonym: hla-g, hdcma22p. Engineered: yes.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 511693. Synthetic: yes. Synthetic construct. Organism_taxid: 32630
|
|
Biol. unit:
|
 |
Trimer (from
)
|
|
Resolution:
|
 |
|
1.90Å
|
R-factor:
|
0.235
|
R-free:
|
0.264
|
|
|
Authors:
|
 |
C.S.Clements,L.Kjer-Nielsen,L.Kostenko,H.L.Hoare,M.A.Dunstone, E.Moses,K.Freed,A.G.Brooks,J.Rossjohn,J.Mccluskey
|
Key ref:
|
 |
C.S.Clements
et al.
(2005).
Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface.
Proc Natl Acad Sci U S A,
102,
3360-3365.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
25-Dec-04
|
Release date:
|
08-Mar-05
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
102:3360-3365
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface.
|
|
C.S.Clements,
L.Kjer-Nielsen,
L.Kostenko,
H.L.Hoare,
M.A.Dunstone,
E.Moses,
K.Freed,
A.G.Brooks,
J.Rossjohn,
J.McCluskey.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
HLA-G is a nonclassical major histocompatibility complex class I (MHC-I)
molecule that is primarily expressed at the fetal-maternal interface, where it
is thought to play a role in protecting the fetus from the maternal immune
response. HLA-G binds a limited repertoire of peptides and interacts with the
inhibitory leukocyte Ig-like receptors LIR-1 and LIR-2 and possibly with certain
natural killer cell receptors. To gain further insights into HLA-G function, we
determined the 1.9-A structure of a monomeric HLA-G complexed to a natural
endogenous peptide ligand from histone H2A (RIIPRHLQL). An extensive network of
contacts between the peptide and the antigen-binding cleft reveal a constrained
mode of binding reminiscent of the nonclassical HLA-E molecule, thereby
providing a structural basis for the limited peptide repertoire of HLA-G. The
alpha3 domain of HLA-G, a candidate binding site for the LIR-1 and -2 inhibitory
receptors, is structurally distinct from the alpha3 domains of classical MHC-I
molecules, providing a rationale for the observed affinity differences for these
ligands. The structural data suggest a head-to-tail mode of dimerization,
mediated by an intermolecular disulfide bond, that is consistent with the
observation of HLA-G dimers on the cell surface.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Overview of the structure of HLA-G. (A) The hc is
shown in purple, [2]M in blue, and the
peptide in green. The position of the Cys-42 Ser mutation is labeled.
(B) Conformation of bound peptide. The corresponding 2F[o]- F[c]
electron density is shown in mesh format. The peptide is in
ball-and-stick format with each amino acid labeled.
|
 |
Figure 4.
Fig. 4. Pocket-mediated interactions of HLA-G. HLA-G
residues are shown in purple, peptide residues are shown in
green, polar contacts are depicted as dashed lines, and water
molecules are shown as blue spheres. (A) Pockets A and B
mediating interactions with P1-Arg and P2-Ile, respectively. (B)
Pockets C and D mediating interactions with P6-His and P2-Pro,
respectively. (C) Pockets E and F mediating interactions with
P7-Leu and P9-Leu, respectively. (D) Overview of the hydrophobic
nature of the HLA-G binding cleft. Hydrophobic regions of the
cleft that bind peptide are shown in green with the important
anchor residue His-70 colored yellow. The pockets are labeled
A-F, and the peptide is depicted as a ball-and-stick structure.
|
 |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
L.Kjer-Nielsen,
O.Patel,
A.J.Corbett,
J.Le Nours,
B.Meehan,
L.Liu,
M.Bhati,
Z.Chen,
L.Kostenko,
R.Reantragoon,
N.A.Williamson,
A.W.Purcell,
N.L.Dudek,
M.J.McConville,
R.A.O'Hair,
G.N.Khairallah,
D.I.Godfrey,
D.P.Fairlie,
J.Rossjohn,
and
J.McCluskey
(2012).
MR1 presents microbial vitamin B metabolites to MAIT cells.
|
| |
Nature,
491,
717-723.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.D.Carosella,
S.Gregori,
N.Rouas-Freiss,
J.LeMaoult,
C.Menier,
and
B.Favier
(2011).
The role of HLA-G in immunity and hematopoiesis.
|
| |
Cell Mol Life Sci,
68,
353-368.
|
 |
|
|
|
|
 |
E.Fainardi,
M.Castellazzi,
M.Stignani,
F.Morandi,
G.Sana,
R.Gonzalez,
V.Pistoia,
O.R.Baricordi,
E.Sokal,
and
J.Peña
(2011).
Emerging topics and new perspectives on HLA-G.
|
| |
Cell Mol Life Sci,
68,
433-451.
|
 |
|
|
|
|
 |
N.G.Walpole,
L.Kjer-Nielsen,
L.Kostenko,
J.McCluskey,
A.G.Brooks,
J.Rossjohn,
and
C.S.Clements
(2010).
The structure and stability of the monomorphic HLA-G are influenced by the nature of the bound peptide.
|
| |
J Mol Biol,
397,
467-480.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.Moreau,
S.Flajollet,
and
E.D.Carosella
(2009).
Non-classical transcriptional regulation of HLA-G: an update.
|
| |
J Cell Mol Med,
13,
2973-2989.
|
 |
|
|
|
|
 |
A.Lightner,
D.J.Schust,
Y.B.Chen,
and
B.F.Barrier
(2008).
The fetal allograft revisited: does the study of an ancient invertebrate species shed light on the role of natural killer cells at the maternal-fetal interface?
|
| |
Clin Dev Immunol,
2008,
631920.
|
 |
|
|
|
|
 |
C.Y.Tan,
J.F.Ho,
Y.S.Chong,
A.Loganath,
Y.H.Chan,
J.Ravichandran,
C.G.Lee,
and
S.S.Chong
(2008).
Paternal contribution of HLA-G*0106 significantly increases risk for pre-eclampsia in multigravid pregnancies.
|
| |
Mol Hum Reprod,
14,
317-324.
|
 |
|
|
|
|
 |
E.D.Carosella,
B.Favier,
N.Rouas-Freiss,
P.Moreau,
and
J.Lemaoult
(2008).
Beyond the increasing complexity of the immunomodulatory HLA-G molecule.
|
| |
Blood,
111,
4862-4870.
|
 |
|
|
|
|
 |
K.Dunker,
G.Schlaf,
J.Bukur,
W.W.Altermann,
D.Handke,
and
B.Seliger
(2008).
Expression and regulation of non-classical HLA-G in renal cell carcinoma.
|
| |
Tissue Antigens,
72,
137-148.
|
 |
|
|
|
|
 |
M.J.Byrne,
and
C.M.Warner
(2008).
MicroRNA expression in preimplantation mouse embryos from Ped gene positive compared to Ped gene negative mice.
|
| |
J Assist Reprod Genet,
25,
205-214.
|
 |
|
|
|
|
 |
R.Apps,
L.Gardner,
and
A.Moffett
(2008).
A critical look at HLA-G.
|
| |
Trends Immunol,
29,
313-321.
|
 |
|
|
|
|
 |
H.Kang,
H.S.Yun,
M.Y.Song,
J.K.Lee,
and
K.Kwack
(2007).
Identification of novel HLA-G subtype, HLA-G*0109, by sequencing in the Korean population.
|
| |
Tissue Antigens,
70,
529-530.
|
 |
|
|
|
|
 |
J.Wischhusen,
A.Waschbisch,
and
H.Wiendl
(2007).
Immune-refractory cancers and their little helpers--an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?
|
| |
Semin Cancer Biol,
17,
459-468.
|
 |
|
|
|
|
 |
K.Kuroki,
and
K.Maenaka
(2007).
Immune modulation of HLA-G dimer in maternal-fetal interface.
|
| |
Eur J Immunol,
37,
1727-1729.
|
 |
|
|
|
|
 |
M.Comiskey,
K.E.Domino,
and
C.M.Warner
(2007).
HLA-G is found in lipid rafts and can act as a signaling molecule.
|
| |
Hum Immunol,
68,
1.
|
 |
|
|
|
|
 |
M.J.Byrne,
G.S.Jones,
and
C.M.Warner
(2007).
Preimplantation embryo development (Ped) gene copy number varies from 0 to 85 in a population of wild mice identified as Mus musculus domesticus.
|
| |
Mamm Genome,
18,
767-778.
|
 |
|
|
|
|
 |
P.Tripathi,
and
S.Agrawal
(2007).
The role of human leukocyte antigen E and G in HIV infection.
|
| |
AIDS,
21,
1395-1404.
|
 |
|
|
|
|
 |
R.Apps,
L.Gardner,
A.M.Sharkey,
N.Holmes,
and
A.Moffett
(2007).
A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1.
|
| |
Eur J Immunol,
37,
1924-1937.
|
 |
|
|
|
|
 |
V.Rebmann,
H.Nückel,
U.Dührsen,
and
H.Grosse-Wilde
(2007).
HLA-G in B-chronic lymphocytic leukaemia: clinical relevance and functional implications.
|
| |
Semin Cancer Biol,
17,
430-435.
|
 |
|
|
|
|
 |
V.Rebmann,
S.Wagner,
and
H.Grosse-Wilde
(2007).
HLA-G expression in malignant melanoma.
|
| |
Semin Cancer Biol,
17,
422-429.
|
 |
|
|
|
|
 |
H.L.Hoare,
L.C.Sullivan,
G.Pietra,
C.S.Clements,
E.J.Lee,
L.K.Ely,
T.Beddoe,
M.Falco,
L.Kjer-Nielsen,
H.H.Reid,
J.McCluskey,
L.Moretta,
J.Rossjohn,
and
A.G.Brooks
(2006).
Structural basis for a major histocompatibility complex class Ib-restricted T cell response.
|
| |
Nat Immunol,
7,
256-264.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.S.Hunt,
D.K.Langat,
R.H.McIntire,
and
P.J.Morales
(2006).
The role of HLA-G in human pregnancy.
|
| |
Reprod Biol Endocrinol,
4,
S10.
|
 |
|
|
|
|
 |
L.C.Sullivan,
H.L.Hoare,
J.McCluskey,
J.Rossjohn,
and
A.G.Brooks
(2006).
A structural perspective on MHC class Ib molecules in adaptive immunity.
|
| |
Trends Immunol,
27,
413-420.
|
 |
|
|
|
|
 |
M.J.Byrne,
J.A.Newmark,
and
C.M.Warner
(2006).
Analysis of the sex ratio in preimplantation embryos from B6.K1 and B6.K2 Ped gene congenic mice.
|
| |
J Assist Reprod Genet,
23,
321-328.
|
 |
|
|
|
|
 |
M.Shiroishi,
K.Kuroki,
L.Rasubala,
K.Tsumoto,
I.Kumagai,
E.Kurimoto,
K.Kato,
D.Kohda,
and
K.Maenaka
(2006).
Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d).
|
| |
Proc Natl Acad Sci U S A,
103,
16412-16417.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Liang,
W.Zhang,
and
A.Horuzsko
(2006).
Human ILT2 receptor associates with murine MHC class I molecules in vivo and impairs T cell function.
|
| |
Eur J Immunol,
36,
2457-2471.
|
 |
|
|
|
|
 |
J.R.Rodgers,
and
R.G.Cook
(2005).
MHC class Ib molecules bridge innate and acquired immunity.
|
| |
Nat Rev Immunol,
5,
459-471.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |